Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Circulating linoleic acid and its interplay with gut microbiota during pregnancy for gestational diabetes mellitus

Fig. 5

Association of linoleic acid-related microbiota and pathways with metabolic markers in early pregnancy. A Associations between Bilophila wadsworthia (average relative abundance = 0.10%) and metabolic markers. All models were adjusted for maternal age (years, continuous), education (primary or middle school, high school, and college or above), gestational age at baseline blood collection (weeks, continuous), parity (nulliparous and multiparous), cigarette smoking (ever and never), alcohol drinking (ever and never), physical activity (continuous, MET-hours/week), pre-pregnancy BMI (< 18.5, 18.5–24, 24–28, and ≥ 28 kg/m2), family history of diabetes (yes and no), and history of GDM (yes and no). B Associations of linoleic acid and metabolic markers with metagenomic pathways. All models were adjusted for GDM status, maternal age, education, gestational age at baseline blood collection pre-pregnancy BMI, and intake of meat, vegetables and fruits, eggs, and dairy product. C Key steps in the D-GALACTUROCAT-PWY are shown with corresponding enzymes. Scatter plots show the correlations between the relative abundance of key enzyme (EC 4.2.1.7) and metabolic markers. D Microbiota contributing to EC 4.2.1.7 enzyme. HbA1c, hemoglobin A1 C; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein

Back to article page